{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:52:29Z","timestamp":1774702349353,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ad.2025.07.007","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T14:59:17Z","timestamp":1752937157000},"page":"T985-T989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Hyperhidrosis, Anticholinergics, and Dementia"],"prefix":"10.1016","volume":"116","author":[{"given":"J.","family":"del Boz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Bautista Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2025.07.007_bib0120","first-page":"ED000154","article-title":"Anticholinergic drugs and dementia: time for transparency in the face of uncertainty","volume":"9","author":"Woodford","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ad.2025.07.007_bib0125","first-page":"CD013540","article-title":"Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome","author":"Taylor-Rowan","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ad.2025.07.007_bib0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.urology.2023.11.033","article-title":"Oxybutynin-associated cognitive impairment: evidence and implications for overactive bladder treatment","volume":"186","author":"Chancellor","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.ad.2025.07.007_bib0135","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00192-021-04909-5","article-title":"A systematic review of neurocognitive dysfunction with overactive bladder medications","volume":"32","author":"Duong","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ad.2025.07.007_bib0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neubiorev.2021.04.031","article-title":"Anticholinergic drugs and the risk of dementia: a systematic review and meta-analysis","volume":"127","author":"Zheng","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ad.2025.07.007_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/dtb.2022.000066","article-title":"Managing drugs with anticholinergic activity","volume":"61","author":"Bishara","year":"2023","journal-title":"Drug Ther Bull"},{"key":"10.1016\/j.ad.2025.07.007_bib0150","doi-asserted-by":"crossref","first-page":"e12290","DOI":"10.1002\/trc2.12290","article-title":"Association between anticholinergic burden and dementia in UK Biobank","volume":"8","author":"Mur","year":"2022","journal-title":"Alzheimers Dement (NY)"},{"key":"10.1016\/j.ad.2025.07.007_bib0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40266-018-00630-z","article-title":"Drugs contributing to anticholinergic burden and risk of fall or fall-related injury among older adults with mild cognitive impairment. Dementia and multiple chronic conditions: a retrospective cohort study","volume":"36","author":"Green","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ad.2025.07.007_bib0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bcp.12617","article-title":"Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis","volume":"80","author":"Ruxton","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ad.2025.07.007_bib0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrd.2017.1","article-title":"Poor medication adherence in clinical trials: consequences and solutions","volume":"16","author":"Breckenridge","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ad.2025.07.007_bib0055","doi-asserted-by":"crossref","first-page":"19f13000","DOI":"10.4088\/JCP.19f13000","article-title":"Anticholinergic drug exposure and the risk of dementia: there is modest evidence for an association but not for causality","volume":"80","author":"Andrade","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ad.2025.07.007_bib0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case\u2013control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ad.2025.07.007_bib0180","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-171174","article-title":"Exposure to strong anticholinergic medications and dementia-related neuropathology in a community-based autopsy cohort","volume":"65","author":"Gray","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ad.2025.07.007_bib0185","first-page":"CD015405","article-title":"Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment","volume":"12","author":"Taylor-Rowan","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ad.2025.07.007_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.regg.2014.10.005","article-title":"Mejorando la prescripci\u00f3n de medicamentos en las personas Mayres: una nueva edici\u00f3n de los criterios STOPP-START","volume":"50","author":"Delgado Silveira","year":"2015","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.ad.2025.07.007_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ad.2014.11.012","article-title":"Systemic treatment of hyperhidrosis","volume":"106","author":"Del Boz","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2025.07.007_bib0200","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00403-023-02587-5","article-title":"Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials","volume":"315","author":"El-Samahy","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ad.2025.07.007_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2024.02.002","article-title":"Risks of dementia after treatment with an anticholinergic, beta-3 agonist, or combination of both for an overactive bladder: a Korean national cohort study","author":"Park","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ad.2025.07.007_bib0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/bju.15040","article-title":"Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study","volume":"126","author":"Welk","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.ad.2025.07.007_bib0215","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40262-020-00975-y","article-title":"Limited systemic exposure with topical glycopyrronium tosylate in primary axillary hyperhidrosis","volume":"60","author":"Pariser","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ad.2025.07.007_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ad.2023.09.006","article-title":"Anticolin\u00e9rgicos t\u00f3picos en el manejo de la hiperhidrosis focal en adultos y ni\u00f1os. Una revisi\u00f3n narrativa","volume":"115","author":"Morgado Carrasco","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2025.07.007_bib0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11940-019-0581-2","article-title":"Diagnosis and management of autonomic dysfunction in dementia syndromes","volume":"21","author":"Allan","year":"2019","journal-title":"Curr Treat Opt Neurol"},{"key":"10.1016\/j.ad.2025.07.007_bib0230","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3233\/JAD-210611","article-title":"The association between hyperhidrosis and dementia: a community-based research","volume":"84","author":"Gan","year":"2021","journal-title":"J Alzheimers Dis"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025005022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025005022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:28:54Z","timestamp":1759336134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731025005022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0001731025005022"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2025.07.007","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Hyperhidrosis, Anticholinergics, and Dementia","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2025.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2024.11.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}